The effect of mepolizumab dosage form on treatment outcomes in severe asthma

The effect of mepolizumab dosage form on treatment outcomes in severe asthma

BackgroundA monoclonal antibody such as mepolizumab typically first appears as a parenteral lyophilized formulation (LYO), then as various parenteral solution forms, and finally as a self-administered form at homecare. While more studies compare mepolizumab safety and efficacy across dosage forms, n...

Full description

Saved in:
Bibliographic Details
Main Authors: Martina Vetchá, Kateřina Kubová, Constantinos Glynos, Sylvie Pavloková, Irena Krčmová, Eva Voláková, Ondřej Fibigr, Beáta Hutyrová, Alena Vlachová, Jiří Zeman, David Vetchý
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Medicine
Subjects:
parenteral dosage form
lyophilized injection
autoinjector
syringe
homecare
severe asthma
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1537074/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2025.1537074/full

Similar Items